Overview

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

Status:
Completed

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to assess the effect Of zoledronic acid on circulating and bone marrow-residing prostate cancer cells in patients with clinically localized prostate cancer

Phase:

Phase 4

Details

Lead Sponsor:

Novartis Pharmaceuticals

Collaborator:

University of Athens

Treatments:

Diphosphonates
Zoledronic Acid